News Success for ex-Pfizer scientists with Novartis dermatology s... Novartis is to acquire Ziarco, a privately held UK company focused on developing new treatments in dermatology.
News Pfizer’s eczema drug Eucrisa approved Pfizer has gained FDA approval for Eucrisa, a new eczema treatment which could achieve peak annual sales of $2 billion a year.
News Sanofi’s dermatitis drug dupilumab fast-tracked by FDA Drug could earn $2.8 billion if approved in AD and asthma
News Giving antibiotics to children increases allergy risk Antibiotics linked with asthma and eczema link.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
